Software Service, Inc.
3733・Standard Market・Information & Communication
Business
Software Service Co., Ltd., founded in 1969, is a company specializing in medical information systems. Its core offerings are the Electronic Medical Record System / Ordering System (e-karte® / NEWTONS2), alongside departmental subsystems, a community-based integrated care system (CareMill®), and a medical imaging management system (SeavoPACS®), among others. Its principal customers are healthcare institutions such as general hospitals, psychiatric hospitals, and dispensing pharmacies, and it operates nationwide through its head office (Osaka), Tokyo branch office, and a nationwide branch network. As of October 2025, the number of facilities using its systems reached 1,000. The corporate group comprises the company itself and two subsidiaries, and it operates under a single segment, the Medical Information Systems Business.
Business Model
The company adopts a vertically integrated model that completes everything from system development to sales, installation, and maintenance within its own group. Revenue is composed of Software (¥11,845 million), Hardware (¥19,129 million), Maintenance Services (¥10,083 million), and Other (¥1,240 million). Maintenance Services represent recurring subscription-type stock revenue delivered via an online network, and this revenue structure accumulates steadily as the number of installed facilities expands. The company adheres to a debt-free management policy, funding all capital needs—including capital expenditures and M&A—from its own resources.
Company Strengths
Since its founding in 1969, the company has consistently maintained a specialization strategy focused on the health, medical, and long-term care fields. As of October 2025, the number of installed facilities reached 1,000 (an increase of 74 facilities year-on-year). The medical business knowledge, product quality, and customer relationships accumulated through long-term specialized operations form a barrier to entry.
Maintenance Services revenue for FY2025 (ending October 2025) was ¥10,083 million (up 9.9% year-on-year). This is recurring revenue that accumulates each period in line with the expansion of the number of installed facilities, forming a stable revenue base that is less susceptible to economic fluctuations. The ordinary profit margin reached the medium-term target of 20% or higher in FY2025 (ending October 2025), achieving an ordinary profit margin of 20.0%.
The order backlog at the end of FY2025 (ending October 2025) was ¥15,824 million (up 36.9% year-on-year), comprising ¥5,135 million in software, ¥10,351 million in hardware, and ¥337 million in other items. Order intake also remained at a high level of ¥36,494 million (up 19.5% year-on-year), securing a substantial portion of revenue recognition for the following period and beyond.
ENVALITH's Perspective
Performance Trend
Over the past five fiscal periods (FY2021 to FY2025), the company maintained a consistent trend of increasing revenue and profit, with revenue growing from ¥25,277 million to ¥42,298 million and operating profit from ¥4,281 million to ¥8,388 million. In the first half of FY2026 (ending October 2026), revenue achieved substantial growth, reaching ¥24,334 million (up 20.8% year on year); however, due to rising hardware procurement costs stemming from surging semiconductor prices such as memory (an external factor) and a higher-than-expected proportion of hardware sales in server replacement projects, the company shifted to a profit decline, with operating profit of ¥4,180 million (down 2.2% year on year) and interim net profit of ¥2,752 million (down 7.7% year on year). Net profit was also weighed down by the recording of ¥240 million in extraordinary losses related to employee dormitory demolition costs. The full-year earnings forecast remains unchanged, with the focus now on margin recovery in the second half.
Growth Strategy
Pursuing sustainable growth through three pillars: realization of medical DX, expansion of stock-type (recurring) revenue, and strengthening profitability
Against the backdrop of the government-led establishment of a nationwide medical information platform, standardization of electronic medical record information, and DX initiatives tied to the revision of medical service fees, the company is actively capturing demand for new installations and replacements. Order intake for the first half of FY2026 (ending October 2026) remained at a high level of ¥23,133 million (up 30.8% year on year), indicating steady progress in capturing this demand.
Demand for additional DX-related systems from existing users has remained solid, with Maintenance Services revenue continuing stable growth at ¥5,517 million (up 12.3% year on year). The company aims to strengthen its stock-type revenue base, whereby maintenance revenue expands automatically as the number of installed facilities accumulates.
In anticipation of future headcount growth, the company is rebuilding its employee dormitory in Osaka into an office building. Demolition costs of ¥240 million were already recorded as an extraordinary loss in the first half of FY2026 (ending October 2026). By developing the foundation for securing and training talent, the company aims to address the shortage of specialized personnel, which represents a constraint on business expansion.
Last updated: July 17, 2026

